argenx (ARGX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
argenx SE relies on Vyvgart sales for the treatment of severe autoimmune pathologies. However, international sanctions and geopolitics complicate biomaterial logistics and global research. The company's explosive growth is driven by the sovereign biotechnology cycle. The EV/EBITDA multiple on the time chart at GURU.Markets contains up-to-date data, where 36.33 reflects the latest value of the metric.
argenx.com - analytical breakdowns and key metrics (ARGX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ARGX - Annual Net Income|Projected Future Earnings argenx SE|ARGX - Market Cap to Earnings|Future Price to Earnings argenx SE|ARGX - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio argenx BVBA|ARGX - Operating profit before amortization|Net earnings per share for the last 12 months argenx|ARGX - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months argenx.com|ARGX - Expected net earnings per share growth this year|Earnings growth forecast for next year argenx SE
Initial company analysis:Argenx ARGX
The scale of immune drug development at argenx SE correlates with the dynamics of the enterprise value-to-EBITDA multiple. This indicator assesses the total business value relative to its ability to generate cash flow before taxes, depreciation, and amortization. The calculation combines market capitalization and net debt, which is critical when modernizing energy-efficient centers and adhering to ESG disposal standards. An increase in this metric signals market optimism, yet warns the investor of the risk of overpayment.
Competitors of argenx SE
EV/EBITDA Multiple BNTX (BioNTech Group)|Total Company Value to Operating Income Before Depreciation Ratio Abivax (ABVX)|ADMA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|protagonist-inc.com (PTGX) - Enterprise Value to EBITDA Ratio|Immunovant (IMVT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kiniksa Pharmaceuticals, Ltd.|Enterprise Value to EBITDA Ratio GRFS|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|PHVS - EV/EBITDA Multiple|abcellera.com (ABCL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|tourmalinebio.com - Business Value to Operating Income Before Depreciation|PGEN (Precigen) - EV/EBITDA Multiple|PHAR - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple NKTR|UPB - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Biopharma Inc ZBIO|IMNM: Enterprise Value to Operating Income Before Depreciation|GOSS: Enterprise Value to EBITDA Ratio|KALV (KalVista Pharma) - Enterprise Value to Operating Income Before Depreciation|SEPN (Septerna Corp) - Enterprise Value to EBITDA Ratio|Pieris Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Savara Inc.|rigel.com (RIGL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ANAB|ATXS - Company Value to EBITDA|EV/EBITDA Multiple ENGN (enGene Bio)|EV/EBITDA Multiple rapt.com RAPT|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation ACRS (aclaristx.com)|KYTX: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Tiziana Life Sciences Ltd. TLSA|Enterprise Value to EBITDA Ratio CABA|Enterprise Value to Operating Income Before Depreciation VTYX (Ventyx Biosciences, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|AVTX: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|Business Value to Operating Income Before Depreciation AGEN|Climb Bio, Inc. - EV/EBITDA Multiple|ZURA - EV/EBITDA Multiple|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Adagene Inc. - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|Enterprise Value to EBITDA Ratio Shattuck Therapeutics (STTK)|EV/EBITDA Multiple EQ|EV/EBITDA Multiple connectbiopharm.com (CNTB)|Immunic - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ATRA|InflaRx GmbH - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio X4 Pharmaceuticals Inc. XFOR|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Celularity|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to EBITDA Ratio barinthusbio.com (BRNS)|Enterprise Value to EBITDA Ratio KZR (Kezar Life Sciences, Inc.)|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV: Enterprise Value to Operating Income Before Depreciation|Q32 Bio Corp - EV/EBITDA Multiple|Company Value to EBITDA geovax.com|EDSA: EV/EBITDA Multiple|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|XTLB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BOLT|hcwbiologics.com (HCWB) - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|aimimmuno.com (AIM) - Company Value to EBITDA|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX (XORTX Therapeutics Inc.) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation HIND|Enterprise Value to EBITDA Ratio REVB|INDP: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|Total Company Value to Operating Income Before Depreciation Ratio calcimedica.com|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|THRD - Enterprise Value to EBITDA Multiple
